Vimarsana
Biggest News Aggregation in the World

Page 3 - Generic Products News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Generic Products. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Generic Products Today - Breaking & Trending Today

Mayne Pharma Group Limited (OTCMKTS:MAYNF) Short Interest Update - Vimarsana News

Mayne Pharma Group Limited (OTCMKTS:MAYNF) Short Interest Update

Mayne Pharma Group Limited (OTCMKTS:MAYNF – Get Rating) was the recipient of a significant decrease in short interest during the month of April. As of April 30th, there was short interest totalling 1,033,200 shares, a decrease of 44.3% from the April 15th total of 1,855,200 shares. Based on an average daily volume of 4,000 shares, […]

Worldwide Chronic Kidney Disease Industry to 2026 - North America is Expected to Hold the Largest Market Share - Vimarsana News

Worldwide Chronic Kidney Disease Industry to 2026 - North America is Expected to Hold the Largest Market Share

Press release content from Business Wire. The AP news staff was not involved in its creation.

Source: apnews.com
(AMRX), (BGNE) - Why BeiGene, T2 Biosystems And Amneal Are Are Moving Today - Vimarsana News

(AMRX), (BGNE) - Why BeiGene, T2 Biosystems And Amneal Are Are Moving Today

Share: BeiGene (NASDAQ: BGNE) shares are trading higher after on Tuesday after the company announced a collaboration agreement with Novartis to developed and commercialize Anti-PD-1 antibody Tislelizumab. BeiGene will receive $650 million upfront and is eligible to receive up to $1.55 billion in milestone payments. BeiGene is a clinical-stage biopharmaceutical company. It's engaged in the discovery and development of molecularly targeted and immuno-oncology drugs for the treatment of cancer. BeiGene’s stock traded up 4.30% to $290.92. The stock has a 52-week high of $322.98 and a 52-week lo...